Exponent VP converts RSUs, net 29,131 EXPO shares

Exponent Inc. executive John Pye reported routine equity compensation activity involving restricted stock units and common shares.

Rhea-AI Filing Summary

Exponent Inc. executive John Pye reported routine equity compensation activity involving restricted stock units and common shares. On March 11, 2026, 5,934 vested restricted stock units were converted into 5,934 shares of common stock on a 1:1 basis, reflecting the vesting of awards originally granted on March 11, 2022.

To cover tax withholding obligations tied to this vesting, 2,384 common shares were withheld by the company at a price of $70.03 per share, a tax-related disposition rather than an open-market sale. After these transactions, Pye directly holds 29,131 shares of Exponent common stock.

Insider Trade Summary

5,934 shares exercised/converted

Exercise 3 txns

Insider Pye John

Role VP Global Offices & Innovation

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	5,934	$0.00	$0.00
Exercise	Common Stock	5,934	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	2,384	$70.03	$167K

Holdings After Transaction: Restricted Stock Units — 0 contracts (Direct); Common Stock — 29,131 shares (Direct)

Footnotes (3)

1. F1. Reflects the conversion of shares of vested Restricted Stock Units granted on March 11, 2022 into shares of Common Stock on a 1:1 basis.
2. F2. Not applicable.
3. F3. Reflects shares of common stock withheld by the Company to satify the tax withholding obligations of the Reporting Person.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Exponent (EXPO) report for John Pye on March 11, 2026?

On March 11, 2026, Exponent VP John Pye converted 5,934 vested restricted stock units into 5,934 common shares. The company then withheld 2,384 shares at $70.03 each to cover related tax obligations, leaving him with 29,131 shares directly held.

Were John Pye’s Exponent (EXPO) transactions open-market stock sales?

No, the Form 4 shows no open-market sales by John Pye. Shares were issued through RSU vesting and some were withheld by the company to satisfy tax obligations, a non-market tax-withholding disposition rather than a discretionary sale into the market.

How many Exponent (EXPO) shares does John Pye hold after the reported Form 4 transactions?

Following the March 11, 2026 RSU vesting and tax withholding, John Pye directly holds 29,131 shares of Exponent common stock. This figure reflects the net position after converting 5,934 restricted stock units and withholding 2,384 shares for tax obligations.

What equity awards were converted in John Pye’s Exponent (EXPO) Form 4 filing?

The filing shows conversion of vested restricted stock units granted on March 11, 2022. On March 11, 2026, 5,934 of these units vested and were converted into 5,934 shares of Exponent common stock on a 1:1 basis, as described in the footnotes.

What does the tax-withholding transaction in Exponent (EXPO) VP John Pye’s Form 4 mean?

The tax-withholding entry reflects 2,384 Exponent shares withheld by the company at $70.03 per share. This satisfies John Pye’s tax obligations associated with the RSU vesting and is classified as a tax-withholding disposition, not an open-market sale of stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/13/2026 - 05:23 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Pye John

(Last) (First) (Middle)

149 COMMONWEALTH DRIVE

(Street)

MENLO PARK CA 94025

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
EXPONENT INC [ EXPO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP Global Offices & Innovation

3. Date of Earliest Transaction (Month/Day/Year)
03/11/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/11/2026		M(1)		5,934	A	(2)	31,515	D
Common Stock	03/11/2026		F(3)		2,384	D	$70.03	29,131	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	03/11/2026		M(1)			5,934	03/11/2026	03/11/2026	Common Stock	5,934	(2)	0	D

Explanation of Responses:

1. Reflects the conversion of shares of vested Restricted Stock Units granted on March 11, 2022 into shares of Common Stock on a 1:1 basis.

2. Not applicable.

3. Reflects shares of common stock withheld by the Company to satify the tax withholding obligations of the Reporting Person.

	By: Wendy Whitehouse For: John Pye	03/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.